144 related articles for article (PubMed ID: 17067438)
1. Increased titres of IgM anti-heparan sulfate antibody in Behçet's disease.
Briani C; Doria A; Marcolongo R; Tognon S; Ruggero S; Toffanin E; Ermani M; Ghirardello A; Zampieri S; Semenzato G
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S104-7. PubMed ID: 17067438
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
3. Human anti-alpha-enolase antibody in sera from patients with Behçet's disease and rheumatologic disorders.
Lee JH; Cho SB; Bang D; Oh SH; Ahn KJ; Kim J; Park YB; Lee SK; Lee KH
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S63-6. PubMed ID: 19796536
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes.
Shibata S; Sasaki T; Harpel P; Fillit H
Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226
[TBL] [Abstract][Full Text] [Related]
5. Anti-alpha-enolase antibodies in Behçet's disease: a marker of mucocutaneous and articular disease activity?
Prado LL; Goncalves CR; Viana VT; Saad CGS; Bonfa E
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):28-32. PubMed ID: 29465373
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
Kang HJ; Lee YW; Han SH; Cho HC; Lee KM
J Korean Med Sci; 1998 Aug; 13(4):400-4. PubMed ID: 9741545
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
[TBL] [Abstract][Full Text] [Related]
9. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.
Delunardo F; Conti F; Margutti P; Alessandri C; Priori R; Siracusano A; Riganò R; Profumo E; Valesini G; Sorice M; Ortona E
Arthritis Res Ther; 2006; 8(3):R71. PubMed ID: 16611372
[TBL] [Abstract][Full Text] [Related]
11. Anti-alpha-enolase antibody as a serologic marker and its correlation with disease severity in intestinal Behçet's disease.
Shin SJ; Kim BC; Kim TI; Lee SK; Lee KH; Kim WH
Dig Dis Sci; 2011 Mar; 56(3):812-8. PubMed ID: 20632102
[TBL] [Abstract][Full Text] [Related]
12. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
13. Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease.
Lee KH; Bang D; Choi ES; Chun WH; Lee ES; Lee S
Arch Dermatol Res; 1999; 291(7-8):374-81. PubMed ID: 10482005
[TBL] [Abstract][Full Text] [Related]
14. Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease.
Krause I; Monselise Y; Milo G; Weinberger A
Clin Exp Rheumatol; 2002; 20(4 Suppl 26):S21-4. PubMed ID: 12371630
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.
Bassyouni IH; Gamal S; Talaat RM; Siam I
Mod Rheumatol; 2014 Mar; 24(2):316-20. PubMed ID: 24593207
[TBL] [Abstract][Full Text] [Related]
16. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
[TBL] [Abstract][Full Text] [Related]
17. Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis?
Berden JH; Termaat RM; Brinkman K; Smeenk RJ; Swaak AJ; Faaber P; Assmann K; van de Heuvel LP; Veerkamp JH
Nephrologie; 1989; 10(3):127-32. PubMed ID: 2532712
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
[TBL] [Abstract][Full Text] [Related]
19. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease.
Ozyazgan S; Uzun H; Onal B; Tuzcu A; Ugurlu S; Andican G
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):71-6. PubMed ID: 24064019
[TBL] [Abstract][Full Text] [Related]
20. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
